Which of your patients should be offered genetic testing for cancer risk?
Give Us Your Feedback
The Use of Genetic Markers to Improve Outcomes in Non-Small Cell Lung Cancer
Comprehensive Screening for Clearer Insight: QNatal® Advanced
CMA analysis identifies homozygous deletion of MCPH1 in 2 brothers with primary Microcephaly-1.
Enrichment of small pathogenic deletions at chromosome 9p24.3 and 9q34.3 involving DOCK8, KANK1, EHMT1 genes identified by using high-resolution oligonucleotide-single nucleotide polymorphism array analysis
Molecular combing compared to Southern blot for measuring D4Z4 contractions in FSHD
Concurrent triplication and uniparental isodisomy: evidence for microhomology-mediated break-induced replication model for genomic rearrangements.
Regions of homozygosity identified by oligonucleotide SNP arrays: evaluating the incidence and clinical utility.